131 related articles for article (PubMed ID: 3171227)
1. Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive.
Novick DM; Farci P; Croxson TS; Taylor MB; Schneebaum CW; Lai ME; Bach N; Senie RT; Gelb AM; Kreek MJ
J Infect Dis; 1988 Oct; 158(4):795-803. PubMed ID: 3171227
[TBL] [Abstract][Full Text] [Related]
2. Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan.
Chung DC; Ko YC; Chen CJ; Chen ER; Wu CC; Wu PS
J Med Virol; 1989 Aug; 28(4):215-8. PubMed ID: 2778445
[TBL] [Abstract][Full Text] [Related]
3. Contrasting prevalence of delta hepatitis markers in parenteral drug abusers with and without AIDS.
Kreek MJ; Des Jarlais DC; Trepo CL; Novick DM; Abdul-Quader A; Raghunath J
J Infect Dis; 1990 Aug; 162(2):538-41. PubMed ID: 2373877
[TBL] [Abstract][Full Text] [Related]
4. Correlation of hepatitis B virus, hepatitis D virus and human immunodeficiency virus type I infection markers in hepatitis B surface antigen positive haemophiliacs and patients without haemophilia with clinical and histopathological outcome of hepatitis.
Wagner N; Rotthauwe HW; Becker M; Dienes HP; Mertens T; Födisch HJ; Brackmann HH
Eur J Pediatr; 1992 Feb; 151(2):90-4. PubMed ID: 1537369
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to hepatitis delta virus in intravenous drug addicts and male homosexuals in Spain.
León P; López JA; Contreras G; Echevarría JM
Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):533-5. PubMed ID: 3141166
[TBL] [Abstract][Full Text] [Related]
6. Increase of the prevalence of hepatitis B virus surface antigen related to immunodeficiency inherent in acquired immune deficiency syndrome (AIDS).
Ouattara SA; Meite M; Aron Y; Akran V; Gody M; Manlan LK; de-The G
J Acquir Immune Defic Syndr (1988); 1990; 3(3):282-6. PubMed ID: 2154578
[TBL] [Abstract][Full Text] [Related]
7. [Absence of delta agent infection in high risk male subjects infected with B virus and human immunodeficiency virus].
Deibis L; Márquez M; Bianco NE; Pérez GE; Machado IV
G E N; 1989; 43(3):202-4. PubMed ID: 2535561
[TBL] [Abstract][Full Text] [Related]
8. Seroepidemiology of hepatitis A, B, and D viruses and human T-lymphocyte tropic viruses in Japanese drug abusers.
Kiyosawa K; Oofusa H; Saitoh H; Sodeyama T; Tanaka E; Furuta S; Itoh S; Ogata H; Kobuchi H; Kameko M
J Med Virol; 1989 Nov; 29(3):160-3. PubMed ID: 2559157
[TBL] [Abstract][Full Text] [Related]
9. Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus.
Housset C; Pol S; Carnot F; Dubois F; Nalpas B; Housset B; Berthelot P; Brechot C
Hepatology; 1992 Apr; 15(4):578-83. PubMed ID: 1551633
[TBL] [Abstract][Full Text] [Related]
10. Influence of human immunodeficiency virus infection on cell-mediated immunity in chronic D hepatitis.
Buti M; Esteban R; Español MT; Malagelada A; Jardi R; Rodriguez-Frias F; Roget M; Guardia J
J Infect Dis; 1991 Jun; 163(6):1351-3. PubMed ID: 1674749
[TBL] [Abstract][Full Text] [Related]
11. The association of hepatitis delta virus and hepatitis B virus in parenteral drug abusers. 1971 to 1972 and 1986 to 1987.
Lange WR; Cone EJ; Snyder FR
Arch Intern Med; 1990 Feb; 150(2):365-8. PubMed ID: 2302011
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis delta virus RNA detection in chronic HBsAg carriers with and without HIV infection.
Castillo I; Bartolomé J; Madejón A; Melero M; Porres JC; Carreño V
Digestion; 1991; 48(3):149-56. PubMed ID: 1916035
[TBL] [Abstract][Full Text] [Related]
13. [Retrospective (1970-1984) serological study of delta antigen and antibody. Observations on seroconversion and absence of delta in non-A, non-B hepatitis].
Stroun J; Peitrequin R; Frei PC
Schweiz Med Wochenschr; 1987 Feb; 117(9):307-14. PubMed ID: 3105053
[TBL] [Abstract][Full Text] [Related]
14. The effect of HIV disease on serum markers of hepatitis delta infection in intravenous drug abusers.
Lake-Bakaar G; Bhat K; Govindarajan S
J Lab Clin Med; 1994 Oct; 124(4):564-8. PubMed ID: 7930880
[TBL] [Abstract][Full Text] [Related]
15. Serological diagnosis of acute delta hepatitis.
Buti M; Esteban R; Jardí R; Esteban JI; Guardia J
J Med Virol; 1986 Jan; 18(1):81-5. PubMed ID: 3944592
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological study of fulminant hepatitis: coinfection with hepatitis B virus and delta agent.
Krajden S; Bishai F; Huang SN; Ronald A; Harris F; Kempston J; Anderson J; Keston S
CMAJ; 1986 Dec; 135(11):1282-5. PubMed ID: 3536053
[No Abstract] [Full Text] [Related]
17. Active viral B hepatitis in parenteral drug abusers with acquired immune deficiency syndrome (AIDS).
Leevy CB; Nurse H; Kapila R
J Assoc Acad Minor Phys; 1989; 1(1):18-9, 22-3. PubMed ID: 2520848
[TBL] [Abstract][Full Text] [Related]
18. HIV, HBV, delta-agent and Treponema pallidum infections in two rural African areas.
de Lalla F; Rizzardini G; Rinaldi E; Santoro D; Zeli PL; Verga G
Trans R Soc Trop Med Hyg; 1990; 84(1):144-7. PubMed ID: 2189236
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus DNA in chronic HBsAg carriers: correlation with HBeAg/anti-HBe status, anti-HD and liver histology.
Stroffolini T; Sagnelli E; Rapicetta M; Felaco FM; Filippini P; Annella T; Petruzziello A; Chionne P; Sarrecchia B; Piccinino F
Hepatogastroenterology; 1992 Feb; 39(1):62-5. PubMed ID: 1568710
[TBL] [Abstract][Full Text] [Related]
20. Minor role of hepatitis B virus in the causation of chronic liver disease in Somalia indicated by a case-control study.
Bile KM; Abdirahman M; Aden C; Norder H; Magnius L; Lindberg G; Nilsson LH
Trans R Soc Trop Med Hyg; 1991; 85(1):104-8. PubMed ID: 1712517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
